REG - Bowleven plc - Block Admission Six Monthly Return

BowlevenAnnouncement

11/11/2019 07:05

RNS Number : 7036S
Bowleven plc
11 November 2019
 


 
 
 
 
 
 
11 November 2019
 
Bowleven plc ('Bowleven')
 
 
Block Admission Six Monthly Return
                                                                                        
This Block Admission Six Monthly Return is intended to comply with the requirements of AIM Rule 29 and Schedule Six.
 



Name of company:


BOWLEVEN PLC




Name of scheme:


1)  BOWLEVEN PLC APPROVED CSOP SCHEME        (WITH UNAPPROVED SCHEDULE)
2)  BOWLEVEN PLC SCHEDULE 4 CSOP SCHEME        (WITH UNAPPROVED SCHEDULE)




Period of return:


From:


9 MAY 2019


To:


8 NOVEMBER 2019




Balance of unallotted securities under scheme(s) from previous return:


659,526




Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):


NIL




Less:  Number of securities issued/allotted under scheme(s) during period:


NIL




Equals:  Balance under scheme(s) not yet issued/allotted at end of period:


659,526




Number and class of share(s) (amount of stock/debit securities) originally admitted and the Date of Admission:


852,105 ORDINARY SHARES
9 MAY 2018




Total number of shares in issue at the end of the period:


335,272,933










 
 
ENQUIRIES
 
For further information, please contact:
 



Bowleven plc








Eli Chahin, Chief Executive


00 44 131 524 5678














Celicourt Communications Ltd








Mark Antelme


00 44 20 8434 2643




Jimmy Lea


















Shore Capital & Corporate Ltd (NOMAD and Broker)








Robert Finlay


00 44 207 601 6100




Antonio Bossi
 







 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BLRBUBDBXSGBGCR